Summary
CME Group Inc. (CME) has filed an 8-K report on February 14, 2024, primarily announcing its financial results for the quarter ended December 31, 2023. The filing incorporates by reference a press release (Exhibit 99.1) which details these results. Investors should note that this press release includes non-GAAP financial measures, such as non-GAAP net income and earnings per share, alongside their GAAP counterparts. Management asserts that these non-GAAP measures offer valuable supplemental information for understanding financial and business trends, facilitating better comparability with prior periods. While these non-GAAP figures are presented to provide a more comprehensive view, they should be considered in conjunction with, and not as a replacement for, the official GAAP financial statements. A reconciliation of the non-GAAP measures to the most directly comparable GAAP measures is provided within the press release, adhering to Regulation G requirements.
Key Highlights
- 1CME Group Inc. reported its financial results for the fourth quarter of 2023 on February 14, 2024.
- 2The 8-K filing includes a press release (Exhibit 99.1) containing the detailed financial results.
- 3The press release presents both GAAP and non-GAAP financial measures, including non-GAAP net income and earnings per share.
- 4Management believes non-GAAP measures provide important supplemental information and enhance comparability.
- 5Reconciliation between non-GAAP and GAAP financial measures is provided in the press release as required by Regulation G.
- 6The filing itself does not contain new financial statements but references an attached press release.